APA (7th ed.) Citation

A, A., DM, K., V, S., IR, P., S, S., B, T., . . . K, S. (2012). Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: Identification of temozolomide as a TOP2A inhibitor. Journal of neuro-oncology, 107(2), 289. https://doi.org/10.1007/s11060-011-0758-3

Chicago Style (17th ed.) Citation

A, Arivazhagan, et al. "Higher Topoisomerase 2 Alpha Gene Transcript Levels Predict Better Prognosis in GBM Patients Receiving Temozolomide Chemotherapy: Identification of Temozolomide as a TOP2A Inhibitor." Journal of Neuro-oncology 107, no. 2 (2012): 289. https://doi.org/10.1007/s11060-011-0758-3.

MLA (9th ed.) Citation

A, Arivazhagan, et al. "Higher Topoisomerase 2 Alpha Gene Transcript Levels Predict Better Prognosis in GBM Patients Receiving Temozolomide Chemotherapy: Identification of Temozolomide as a TOP2A Inhibitor." Journal of Neuro-oncology, vol. 107, no. 2, 2012, p. 289, https://doi.org/10.1007/s11060-011-0758-3.